Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Brand Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Brand Drugsmarket, defines the market attractiveness level of Brand Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Brand Drugs industry, describes the types of Brand Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Brand Drugs market and the development prospects and opportunities of Brand Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Brand Drugs market in Chapter 13.
By Player:
Takeda
Amgen
GlaxoSmithKline (GSK)
Roche
Eli Lilly
Allergan
AbbVie
Boehringer Ingelheim
Gilead Sciences
Merck & Co (MSD)
Bristol-Myers Squibb
Teva
Novo Nordisk
Bayer
AstraZeneca
Pfizer
Shire
Johnson & Johnson
Sanofi
Novartis
By Type:
Biopharmaceutical
Chemistry Medicine
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Brand Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Brand Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Brand Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Brand Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Brand Drugs Market Analysis and Outlook to 2022
-
7.1 Global Brand Drugs Consumption (2017-2022)
-
7.2 United States Brand Drugs Consumption (2017-2022)
-
7.3 Europe Brand Drugs Consumption (2017-2022)
-
7.4 China Brand Drugs Consumption (2017-2022)
-
7.5 Japan Brand Drugs Consumption (2017-2022)
-
7.6 India Brand Drugs Consumption (2017-2022)
-
7.7 South Korea Brand Drugs Consumption (2017-2022)
8 Region and Country-wise Brand Drugs Market Analysis and Outlook to 2028
-
8.1 Global Brand Drugs Consumption Forecast (2022-2028)
-
8.2 United States Brand Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Brand Drugs Consumption Forecast (2022-2028)
-
8.4 China Brand Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Brand Drugs Consumption Forecast (2022-2028)
-
8.6 India Brand Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Brand Drugs Consumption Forecast (2022-2028)
9 Global Brand Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Brand Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemistry Medicine Consumption and Growth Rate (2017-2022)
-
9.2 Global Brand Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Brand Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Brand Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemistry Medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Brand Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Brand Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Brand Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Brand Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Brand Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Brand Drugs Market Competitive Analysis
-
14.1 Takeda
-
14.1.1 Takeda Company Details
-
14.1.2 Takeda Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Brand Drugs Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Brand Drugs Product and Service
-
14.3 GlaxoSmithKline (GSK)
-
14.3.1 GlaxoSmithKline (GSK) Company Details
-
14.3.2 GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline (GSK) Brand Drugs Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Brand Drugs Product and Service
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Details
-
14.5.2 Eli Lilly Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly Brand Drugs Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Brand Drugs Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Brand Drugs Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Brand Drugs Product and Service
-
14.9 Gilead Sciences
-
14.9.1 Gilead Sciences Company Details
-
14.9.2 Gilead Sciences Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Gilead Sciences Brand Drugs Product and Service
-
14.10 Merck & Co (MSD)
-
14.10.1 Merck & Co (MSD) Company Details
-
14.10.2 Merck & Co (MSD) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck & Co (MSD) Brand Drugs Product and Service
-
14.11 Bristol-Myers Squibb
-
14.11.1 Bristol-Myers Squibb Company Details
-
14.11.2 Bristol-Myers Squibb Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bristol-Myers Squibb Brand Drugs Product and Service
-
14.12 Teva
-
14.12.1 Teva Company Details
-
14.12.2 Teva Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Teva Brand Drugs Product and Service
-
14.13 Novo Nordisk
-
14.13.1 Novo Nordisk Company Details
-
14.13.2 Novo Nordisk Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novo Nordisk Brand Drugs Product and Service
-
14.14 Bayer
-
14.14.1 Bayer Company Details
-
14.14.2 Bayer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bayer Brand Drugs Product and Service
-
14.15 AstraZeneca
-
14.15.1 AstraZeneca Company Details
-
14.15.2 AstraZeneca Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 AstraZeneca Brand Drugs Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer Brand Drugs Product and Service
-
14.17 Shire
-
14.17.1 Shire Company Details
-
14.17.2 Shire Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Shire Brand Drugs Product and Service
-
14.18 Johnson & Johnson
-
14.18.1 Johnson & Johnson Company Details
-
14.18.2 Johnson & Johnson Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Johnson & Johnson Brand Drugs Product and Service
-
14.19 Sanofi
-
14.19.1 Sanofi Company Details
-
14.19.2 Sanofi Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Sanofi Brand Drugs Product and Service
-
14.20 Novartis
-
14.20.1 Novartis Company Details
-
14.20.2 Novartis Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Novartis Brand Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Brand Drugs
-
Figure Brand Drugs Picture
-
Table Global Brand Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Brand Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Brand Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Brand Drugs Consumption by Country (2017-2022)
-
Figure United States Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Chemistry Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemistry Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Brand Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Brand Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Brand Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Brand Drugs Product and Service
-
Table GlaxoSmithKline (GSK) (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline (GSK) Brand Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Brand Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Brand Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Brand Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Brand Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Brand Drugs Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Brand Drugs Product and Service
-
Table Merck & Co (MSD) (Foundation Year, Company Profile and etc.)
-
Table Merck & Co (MSD) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co (MSD) Brand Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Brand Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Brand Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Brand Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Brand Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Brand Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Brand Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Brand Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Brand Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Brand Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Brand Drugs Product and Service
-
